Prelude Therapeutics, Inc. (PRLD)
1.65
-0.05
(-2.94%)
USD |
NASDAQ |
Dec 10, 16:00
1.65
0.00 (0.00%)
After-Hours: 16:53
Prelude Therapeutics Total Assets (Quarterly): 94.76M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 6.330B |
| Nautilus Biotechnology, Inc. | 200.92M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| ALX Oncology Holdings, Inc. | 82.72M |
| Erasca, Inc. | 420.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.22M |
| Shareholders Equity (Quarterly) | 58.53M |
| Debt to Equity Ratio | 0.305 |
| Current Ratio | 3.207 |
| Net Debt Paydown Yield | 0.09% |